Categories: News

STRATA Skin Sciences to Present at the H.C. Wainwright Bioconnect Virtual Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

HORSHAM, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that members of Management will participate in the upcoming H.C. Wainwright Bioconnect Virtual Conference.

A Pre-recorded presentation will be available on Monday, January 10th at 7:00 am Eastern Time. Interested parties may access a webcast of the presentation on the investor section of the Company’s website www.strataskinsciences.com.

About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® and Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions.

The Company’s proprietary XTRAC and recently acquired Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. The technology is covered by multiple patents.

STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

Investor Contact

Jack Droogan
(203) 585-4140
ir@strataskin.com

Staff

Recent Posts

Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution

SINGAPORE, Oct. 8, 2025 /PRNewswire/ -- Neopharma Technologies Ltd ("Neopharma"), a digital health company pioneering…

3 hours ago

CERTIFY Health Releases New Insights Brief Revealing How Practices Achieve 400-600% ROI by Automating From the Point of Check-In

Data from 700+ healthcare leaders and 1,000+ practices shows measurable gains in revenue recovery, staff…

3 hours ago

EMA Wellness Bolsters Executive Leadership to Scale its Market Leading Clinical Trial Platform

New CMO, EVP Operations and SVP Clinical Solutions bring track records of scalable growth and…

3 hours ago

AYUMETRIX Launches Nova: Smart AI Companion for Wellness and Diagnostics

LAKE OSWEGO, Ore., Oct. 8, 2025 /PRNewswire/ -- AYUMETRIX, an early innovator for modern, at-home…

3 hours ago

eschbach Awarded Two Honors in the 2025 Pharmaceutical Technology Excellence Awards for Innovations in Pharmaceutical Manufacturing

BOSTON, Oct. 8, 2025 /PRNewswire/ -- eschbach, developer of Shiftconnector®, an intelligent operations platform for…

3 hours ago

WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $478,000

JERSEY CITY, N.J., Oct. 8, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of…

9 hours ago